Bollerup, Signe
41  Ergebnisse:
Personensuche X
?
1

Clinical trial: An open‐label, randomised trial of differen..:

Johannessen, Asgeir ; Reikvam, Dag Henrik ; Aleman, Soo...
Alimentary Pharmacology & Therapeutics.  60 (2024)  4 - p. 434-445 , 2024
 
?
2

Amantadine for COVID-19 treatment (ACT) study: a randomized..:

Weis, Nina ; Bollerup, Signe ; Sund, Jon Dissing...
Clinical Microbiology and Infection.  29 (2023)  10 - p. 1313-1319 , 2023
 
?
6

Psychological Distress among Hospitalized COVID-19 Patients..:

Moseholm, Ellen ; Midtgaard, Julie ; Bollerup, Signe...
International Journal of Environmental Research and Public Health.  19 (2022)  16 - p. 10097 , 2022
 
?
7

Incidence of Hepatocellular Carcinoma and Decompensated Liv..:

Bollerup, Signe ; Engsig, Frederik ; Hallager, Sofie...
Journal of Hepatocellular Carcinoma.  9 (2022)  - p. 1093-1104 , 2022
 
?
12

Incidence of Hepatocellular Carcinoma and Decompensated Liv..:

Bollerup, Signe ; Engsig, Frederik ; Hallager, Sofie...
Bollerup , S , Engsig , F , Hallager , S , Mocroft , A , Roege , B T , Christensen , P B , Laursen , A L , Krarup , H , Clausen , M R , Thielsen , P , Madsen , L G , Noerregaard , L , Barfod , T S , Balslev , U , Tarp , B , Hansen , J B , Mygind , L H , Gerstoft , J & Weis , N 2022 , ' Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population ' , Journal of Hepatocellular Carcinoma , vol. 9 , pp. 1093-1104 . https://doi.org/10.2147/JHC.S372571.  , 2022
 
?
14

Incidence of Hepatocellular Carcinoma and Decompensated Liv..:

Bollerup, Signe ; Engsig, Frederik ; Hallager, Sofie...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JHC.S372571.  , 2022
 
1-15